Stock & Company Details
Immatics N.V $IMTX
Price:
46,691,331
134M
$1.4B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
0.00
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
IMTX technical indicators
Latest Immatics N.V (IMTX) technical indicators as of 2026-07-01: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
48.38 7.7%
MACD:
-0.19 11.5%
SMA 50:
$10.53 0.3%
SMA 200:
$9.96 0.2%
EMA 20:
$9.85 0.0%
Bollinger Bands:
10.37 / 8.83
Stochastic:
70.09 10.0%
ADX 14:
16.75 6.8%
ATR 14:
0.54 1.8%
CCI 20:
65.07 6.6%
OBV:
11.23M 2.3%
ROC 12:
5.01% 57.6%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.
Finance Bot
Ask your questions
Start by typing a question below.
